ARCHIVES

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

This article is from The Cancer Letter archive.

Vol. 25 No. 21 | May 28, 1999

Download PDF Visit The Full Archive

Related Articles

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976

Cooperative Group Trials Approved By NCI Are Listed

August 26, 2005

In Brief: ONS Invites Proposals For Research On Hazards Of Chemotherapy; UTSCC Adopts Code Of Ethics

August 31, 1984

DCT To Examine Groups’ Studies, Directions, Role in 2000 A.D. Goal

June 8, 1984

In Brief: Rosenberg, Taniguchi To Share Hammer 1985 Prize; Dennis Cain Moves To DCT From DEA Grants Review

December 6, 1985